Free Newsletter
Whistleblowers allege problems with Wyeth's Prevnar
Two former Wyeth workers continue to cause controversy for Wyeth's blockbuster vaccine Prevnar. Wyeth disclosed recently that the workers' whistleblower suits accused the company of making false statements to the government concerning manufacturing problems with the vaccine.
Anthony Sokol, a manufacturing scientist, says he was fired after raising concerns regarding the vaccine and that Wyeth had concealed and misrepresented the data it gave to the government. Sokol's suit alleges he was fired in 2005. Prevnar earned $2.4 billion in sales last year.
- read the report from the Wall Street Journal
Related Article:
Pharma execs practice positive thinking. Report
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FierceVaccines email newsletter for FREE!
Be the first to comment